Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
R Niehues, … , H K Harms, T Marquardt
R Niehues, … , H K Harms, T Marquardt
Published April 1, 1998
Citation Information: J Clin Invest. 1998;101(7):1414-1420. https://doi.org/10.1172/JCI2350.
View: Text | PDF
Research Article Article has an altmetric score of 12

Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.

  • Text
  • PDF
Abstract

Phosphomannose isomerase (PMI) deficiency is the cause of a new type of carbohydrate-deficient glycoprotein syndrome (CDGS). The disorder is caused by mutations in the PMI1 gene. The clinical phenotype is characterized by protein-losing enteropathy, while neurological manifestations prevailing in other types of CDGS are absent. Using standard diagnostic procedures, the disorder is indistinguishable from CDGS type Ia (phosphomannomutase deficiency). Daily oral mannose administration is a successful therapy for this new type of CDG syndrome classified as CDGS type Ib.

Authors

R Niehues, M Hasilik, G Alton, C Körner, M Schiebe-Sukumar, H G Koch, K P Zimmer, R Wu, E Harms, K Reiter, K von Figura, H H Freeze, H K Harms, T Marquardt

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1982 1972 1959 1953 Total
Citations: 2 4 6 5 13 14 6 13 7 5 12 14 5 16 11 13 12 15 11 20 13 11 13 21 19 19 22 5 1 1 1 1 331
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2008 (15)

Title and authors Publication Year
Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib
YS Liem, L Bode, HH Freeze, FW Leebeek, AA Zandbergen, JH Wilson
Nature Clinical Practice Gastroenterology & Hepatology 2008
Long-standing mild hypertransaminasaemia caused by congenital disorder of glycosylation (CDG) type IIx
PL Calvo, S Pagliardini, M Baldi, A Pucci, L Sturiale, D Garozzo, T Vinciguerra, C Barbera, J Jaeken
Journal of Inherited Metabolic Disease 2008
Dolichol-phosphate mannose synthase: Structure, function and regulation
Y Maeda, T Kinoshita
Biochimica et Biophysica Acta (BBA) - General Subjects 2008
Development of liver disease despite mannose treatment in two patients with CDG-Ib
K Mention, F Lacaille, V Valayannopoulos, S Romano, A Kuster, M Cretz, H Zaidan, L Galmiche, F Jaubert, Y Keyzer, N Seta, P Lonlay
Molecular Genetics and Metabolism 2008
Impact of glycans on T-cell tolerance to glycosylated self-antigens
AW Purcell, IR van Driel, PA Gleeson
Immunology and Cell Biology 2008
A "Glyconutrient Sham"
RL Schnaar, HH Freeze
Glycobiology 2008
Evaluation of protein safety in the context of agricultural biotechnology
B Delaney, J Astwood, H Cunny, R Conn, C Herouetguicheney, S Macintosh, L Meyer, L Privalle, Y Gao, J Mattsson
Food and Chemical Toxicology 2008
Anomalies congénitales de glycosylation des glycoprotéines sériques
P Lonlay, N Seta
EMC - Pédiatrie - Maladies infectieuses 2008
Anomalies congénitales de glycosylation
P Lonlay, V Valayannopoulos, T Dupré, S Vuillaumier-Barrot, N Seta
Archives de Pédiatrie 2008
Defecto congénito de glucosilación tipo Ib. Experiencia en el tratamiento con manosa
EM Hernández, AI Pajares, BP González, MJ Crespo, FL Pérez, JM López-Manzanares, MU Pérez, CP Silvestre
Anales de Pediatría 2008
RECURRENT THROMBO-EMBOLISM IN A CHILD WITH A CONGENITAL DISORDER OF GLYCOSYLATION (CDG) TYPE IB AND TREATMENT WITH MANNOSE
RY Tamminga, DJ Lefeber, WA Kamps, FJ van Spronsen
Pediatric Hematology-Oncology 2008
Mannose Inhibits Hyaluronan Synthesis by Down-regulation of the Cellular Pool of UDP- N -acetylhexosamines
TA Jokela, M Jauhiainen, S Auriola, M Kauhanen, R Tiihonen, MI Tammi, RH Tammi
The Journal of biological chemistry 2008
Screening Using Serum Percentage of Carbohydrate-Deficient Transferrin for Congenital Disorders of Glycosylation in Children with Suspected Metabolic Disease
C Pérez-Cerdá, D Quelhas, AI Vega, J Ecay, L Vilarinho, M Ugarte
Clinical chemistry 2008
Glycoscience
BO Fraser-Reid, K Tatsuta, J Thiem
2008
Laboratory Guide to the Methods in Biochemical Genetics
N Blau, M Duran, KM Gibson
2008

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 6 patents
Referenced in 1 Wikipedia pages
Referenced in 1 clinical guideline sources
81 readers on Mendeley
See more details